Related Experiment Video
Updated: Jan 12, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
PDGFRα governs multiple cellular signals and plays a protective role in tumor progression
Masao Hayashi1, Noriko Okuno2, Le Thi Thu Trang2
1Department of Pathology, Academic Assembly Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan; Department of Dermatology, Academic Assembly Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.
Abstract:
Extensive research has been done on the molecular mechanisms of tumor development and growth. However, multiple aspects remain elusive. We examined cellular signaling mechanisms involving platelet-derived growth factor (PDGF) and its receptor (PDGFR), using adult PDGFRα conditional knockout (α-KO) mice implanted with Lewis lung carcinoma (LLC) cells, which express PDGFRα. Unexpectedly, α-KO mice exhibited larger tumors and extensive lung metastasis compared to control mice. Mechanistically, under the activation of PDGF-BB-PDGFRα signal axis in LLC cells, transforming growth factor-α (TGF-α) induced accelerated tumor growth via epidermal growth factor receptor (EGFR) signal. Insufficient vascular development with lower pericyte coverage was also noted, leading to hypoxia and increased expression of transforming growth factor-β (TGF-β), which induced as a critical signaling molecule determining lung metastatic changes with the AKT1 activity. Our findings suggested that PDGFRα in interstitial cells may serve a protective role against tumor progression and selective inhibition of PDGFRα in tumor cells could offer a more targeted therapeutic approach for cancer patients. Statement of significance: PDGFRα in interstitial cells in tumors governs multiple cellular signals such as PDGF-BB, TGF-α, and TGF-β and plays a protective role in tumor progression.
Insights
Platelet-derived growth factor receptor alpha (PDGFRα) in tumor cells unexpectedly promotes tumor growth and metastasis. Inhibiting PDGFRα in tumor cells may offer a targeted cancer therapy approach.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor development involves complex molecular mechanisms, with many aspects still unclear.
- Platelet-derived growth factor (PDGF) and its receptor (PDGFR) signaling pathways are implicated in cancer progression.
Purpose of the Study:
- To investigate the role of PDGFRα in tumor progression and metastasis.
- To elucidate the signaling pathways regulated by PDGFRα in the tumor microenvironment.
Main Methods:
- Utilized adult PDGFRα conditional knockout (α-KO) mice implanted with Lewis lung carcinoma (LLC) cells.
- Analyzed tumor growth, lung metastasis, vascularization, and key signaling molecules (PDGF, TGF-α, TGF-β, EGFR, AKT1).
Main Results:
- α-KO mice showed significantly larger tumors and increased lung metastasis compared to controls.
- PDGF-BB-PDGFRα signaling in LLC cells, activated by TGF-α, accelerated tumor growth via EGFR.
- Hypoxia due to poor vascularization in α-KO mice led to increased TGF-β, promoting lung metastasis via AKT1.
Conclusions:
- PDGFRα in interstitial cells plays a protective role against tumor progression.
- Selective inhibition of PDGFRα in tumor cells could be a potential targeted cancer therapy.
Related Concept Videos
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
The Ras Gene
Ras is a...

